Corteva, Inc. CTVA
78.52
(0.93)
(1.17%)
as of 25 Sep
- Market cap
- $53.0B
- P/E
- 52.0×
Follow CTVA
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
56.09 | 49.24 | 42.42 | 28.90 |
+8 more quarters Free account |
P/S ratio |
3.18 | 3.15 | 2.62 | 2.63 | |
P/FCF ratio |
85.92 | 26.91 | 15.89 | 17.11 | |
P/Operating CF |
(121.51) | (19.47) | 10.42 | 237.83 | |
P/B ratio |
2.23 | 2.29 | 1.87 | 1.80 | |
Price to Tangible BV |
8.14 | 9.31 | 8.11 | 7.04 | |
EV/Sales |
3.32 | 3.22 | 2.51 | 2.73 | |
EV/EBITDA |
19.71 | 18.34 | 14.21 | 12.89 | |
EV/Operating CF |
48.83 | 21.98 | 12.81 | 14.88 | |
EV/FCF |
89.73 | 27.57 | 15.21 | 17.77 | |
Quick Ratio |
1.03 | 0.93 | 0.90 | 1.00 | |
Current Ratio |
1.52 | 1.47 | 1.43 | 1.58 | |
Net Debt/EBITDA |
1.25 | 1.17 | 10.96 | (74.46) | |
Debt/Assets |
11.71% | 7.86% | 6.02% | 10.36% | |
Debt/Equity |
0.19 | 0.14 | 0.11 | 0.17 | |
Asset Turnover |
0.43 | 0.42 | 0.42 | 0.42 | |
Operating CF/Net income |
(0.40) | (4.02) | (7.93) | (0.60) | |
Capex/Depreciation |
(0.36) | (0.27) | (0.63) | (0.52) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.08% | 6.95% | 10.56% | 13.41% | |
Selling, General and Administrative Expense of Revenue |
18.25% | 17.88% | 21.99% | 27.69% | |
Intangible Assets out of Total Assets |
0.44 | 0.43 | 0.44 | 0.45 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.00 | (0.01) | (0.02) | (0.01) | |
Graham Number |
35.93 | 37.41 | 35.71 | 44.44 | |
Earnings Yield |
1.78% | 2.03% | 2.36% | 3.46% | |
Free Cash Flow Yield |
1.16% | 3.72% | 6.29% | 5.85% | |
Revenue per Share |
9.54 | 7.29 | 5.75 | 3.86 | |
Operating CF per Share |
(0.70) | (4.30) | 6.43 | 0.28 | |
Capex per Share |
(0.18) | (0.12) | (0.29) | (0.23) | |
Free Cash Flow per Share |
(0.88) | (4.42) | 6.15 | 0.05 | |
Cash per Share |
3.54 | 2.92 | 6.66 | 3.81 | |
Shareholders Equity per Share |
37.99 | 36.59 | 35.86 | 37.51 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
37.99 | 36.59 | 35.86 | 37.51 | |
Free Cash Flow |
(587.00) | (2,972.00) | 4,181.00 | 37.00 | |
Working Capital |
5,568.00 | 5,531.00 | 5,210.00 | 6,018.00 | |
Capital Expenditures |
(121.00) | (81.00) | (194.00) | (156.00) | |
Net Current Asset Value |
118.00 | (727.00) | (1,124.00) | (299.00) | |
EV/EBIT |
33.64 | 29.70 | 23.36 | 19.08 | |
Capex to Sales |
0.02 | 0.02 | 0.05 | 0.06 | |
Net Profit Margin |
18.20% | 14.68% | (14.12%) | (12.22%) | |
Price to Operating Income |
32.21 | 28.99 | 24.40 | 18.36 | |
| Other line items | |||||
Average Receivables |
8,685.00 | 8,691.00 | 6,023.50 | 7,217.50 | |
Average Payables |
3,893.00 | 4,046.00 | 4,218.50 | 4,045.00 | |
Average Inventory |
4,379.50 | 5,167.00 | 5,549.50 | 5,492.00 | |
Average Assets |
41,700.50 | 42,420.00 | 41,835.00 | 42,053.00 | |
Average Common Equity |
25,777.00 | 24,566.00 | 24,208.00 | 25,220.00 |
Columns are period end dates